// App-Quantinova.ai

: PDCT-08. SUPERIOR OUTCOME FOR BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION

Researchers

Presenter

  • Murali Chintagumpala

Principal Investigators

  • Sonika Dahiya

  • Peter Dirks

  • Ira Dunkel

  • David Eisenstat

  • Elizabeth Finch

  • Jonathan Finlay

  • Didier Frappaz

  • Maria Luisa Garre

  • Karen Gauvain

  • Anne Grete Bechensteen

  • Jordan Hansford

  • Peter Hauser

  • Annie Huang

  • Matthias Karajannis

  • Gurcharanjeet Kaur

  • Valerie Larouche

  • Alvaro Lassaletta

  • Sarah Leary

  • Frank Lin

  • Tara McKeown

  • Til Milde

  • Andres Morales La Madrid

  • Helena Morse

  • Naureen Mushtaq

  • Diana Osorio

  • Roger Packer

  • Zdenek Pavelka

  • Duarte Salgado

  • Magnus Sabel

  • Palma Solano

  • Jack Su

  • David Sumerauer

  • Helen Toledano

  • Cornelis van Tilburg

  • Bev Wilson

  • Eric Bouffet

  • Cynthia Hawkins

  • Uri Tabori

Medical Centers

  • Texas Childrens Cancer Center, Houston, TX

  • Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain

  • Washington University School of Medicine, St. Louis, Missouri, St Louis MO, USA

  • Developmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Stollery Children's Hospital, Edmonton, AB, Canada

  • University of North Carolina, Chapel Hill, NC

  • Nationwide Childrens Hospital and The Ohio State University College of Medicine, Columbus, OH

  • Institute d’Hémato-Oncologie Pédiatrique, Lyon, France

  • G Gaslini Children's Hospital, Genova, Italy

  • Washington University School of Medicine, St. Louis, MO

  • Oslo University Hospital, Oslo, Norway

  • Children's Cancer Centre, The Royal Children's Hospital Melbourne, Melbourne, Australia

  • Semmelweis University, Budapest, Hungary

  • Hospital for Sick Children, Toronto, ON, Canada

  • Nemours/A. I. duPont Hospital for Children, Wilmington, DE

  • Universite Laval, Quebec, QC, Canada

  • Hospital Infantil Universitario Nino Jesus, Madrid, Spain

  • Hopp Childrens Cancer Center at NCT Heidelberg (KiTZ), Heidelberg, Germany

  • Hospital Sant Joan de Deu de Barcelona, Barcelona, Spain

  • Lund University Hospital, Lund, Sweden

  • Aga Khan University, Karachi, Pakistan

  • The Ohio State Univerisity, Columbus, OH

  • Children's National Health System, Washington, DC

  • University Hospital Brno, Brno, Czech Republic

  • Portuguese Cancer Institute, Lisbon, Portugal

  • Queen Sylvia Childrens Hospital, Gothenburg, Sweden

  • Hospital Virgen del Rocio, Sevilla, Spain

  • University Hospital Motol, Prague, Czech Republic

  • Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Tel Avivi, Israel,

  • University of Alberta, Edmonton, AB, Canada

  • University of Toronto, Toronto, ON, Canada

Locations

  • United States

  • Spain

  • Canada

  • France

  • Italy

  • Norway

  • Australia

  • Hungary

  • Germany

  • Sweden

  • Pakistan

  • Czech Republic

  • Portugal

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gliomas

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved